Therapeutic use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for the 3-nitropropionic-acid-induced behavioral deficits in a mouse model of Huntington's disease

R A Myers; Gary Dunbar

Therapeutic use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for the 3-nitropropionic-acid-induced behavioral deficits in a mouse model of Huntington's disease

Research output: Other contribution

Original language	English
State	Published - May 20 2005

Cite this

@misc{2d091550401b42e58d3fd9c81ca1dafb,

title = "Therapeutic use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for the 3-nitropropionic-acid-induced behavioral deficits in a mouse model of Huntington's disease",

author = "Myers, {R A} and Gary Dunbar",

year = "2005",

month = may,

day = "20",

language = "English",

type = "Other",

}

Therapeutic use of the substituted pyrimidine, KP544, as a potential pharmacotherapy for the 3-nitropropionic-acid-induced behavioral deficits in a mouse model of Huntington's disease

Fingerprint

Cite this